Douglass Winthrop Advisors, LLC Abbott Laboratories Transaction History

Douglass Winthrop Advisors, LLC

$5.09 Billion
Q3 2024

A detailed history of Douglass Winthrop Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Douglass Winthrop Advisors, LLC holds 42,978 shares of ABT stock, worth $4.85 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

42,978

Previous 41,589 3.34%

Holding current value

$4.85 Million

Previous $4.32 Million 13.38%

% of portfolio

0.1%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $138,997 - $164,082	1,389 Added 3.34%	42,978 $4.9 Million
Q2 2024 Aug 07, 2024	SELL	$100.73 - $112.44 $168,420 - $187,999	-1,672 Reduced 3.86%	41,589 $4.32 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $38,441 - $42,456	-351 Reduced 0.8%	43,261 $4.92 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $69,068 - $82,870	-723 Reduced 1.63%	43,612 $4.22 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $33,559 - $37,392	-333 Reduced 0.75%	44,335 $4.83 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $37,291 - $43,893	-385 Reduced 0.85%	44,668 $4.52 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $15,589 - $18,289	-164 Reduced 0.36%	45,053 $4.95 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $186,456 - $215,881	-1,927 Reduced 4.09%	45,217 $4.38 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $9,594 - $11,596	94 Added 0.2%	47,144 $5.12 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $211,621 - $258,058	-1,856 Reduced 3.8%	47,050 $5.57 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $99,933 - $122,362	-865 Reduced 1.74%	48,906 $6.88 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $107,210 - $118,606	-919 Reduced 1.81%	49,771 $5.88 Million
Q2 2021 Aug 02, 2021	BUY	$105.79 - $124.53 $47,288 - $55,664	447 Added 0.89%	50,690 $5.88 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $558,240 - $657,691	5,129 Added 11.37%	50,243 $6.02 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $62,790 - $68,423	598 Added 1.34%	45,114 $4.94 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $13,746 - $16,693	150 Added 0.34%	44,516 $4.85 Million
Q2 2020 Jul 17, 2020	BUY	$76.57 - $98.0 $397,704 - $509,012	5,194 Added 13.26%	44,366 $4.06 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $157,678 - $230,568	-2,510 Reduced 6.02%	39,172 $3.09 Million
Q4 2019 Jan 10, 2020	SELL	$78.51 - $87.4 $64,770 - $72,105	-825 Reduced 1.94%	41,682 $3.62 Million
Q3 2019 Oct 08, 2019	SELL	$81.84 - $88.74 $112,530 - $122,017	-1,375 Reduced 3.13%	42,507 $3.56 Million
Q2 2019 Jul 10, 2019	SELL	$72.88 - $85.0 $218,640 - $255,000	-3,000 Reduced 6.4%	43,882 $3.69 Million
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $57,942 - $70,052	-875 Reduced 1.83%	46,882 $3.75 Million
Q4 2018 Jan 16, 2019	SELL	$65.56 - $74.27 $34,615 - $39,214	-528 Reduced 1.09%	47,757 $3.45 Million
Q3 2018 Oct 12, 2018	SELL	$60.81 - $73.36 $744,618 - $898,293	-12,245 Reduced 20.23%	48,285 $3.54 Million
Q2 2018 Jul 24, 2018	BUY	$57.57 - $63.54 $951,286 - $1.05 Million	16,524 Added 37.55%	60,530 $3.69 Million
Q1 2018 May 08, 2018	BUY	$56.27 - $63.62 $102,692 - $116,106	1,825 Added 4.33%	44,006 $2.64 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $42,944 - $45,976	800 Added 1.93%	42,181 $2.41 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $1.99 Million - $2.22 Million	41,381	41,381 $0

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglass Winthrop Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglass Winthrop Advisors, LLC with notifications on news.

Account

Douglass Winthrop Advisors, LLC Abbott Laboratories Transaction History